TVTX
TVTX
US89422G1076
Travere Therapeutics, Inc.
Loading chart...

Valuation & History

Quarterly trend of key valuation metrics

Metric
Current (TTM) TTM Baseline
Q2 '26 30.06.2026
Q1 '26 31.03.2026
Q4 '25 31.12.2025
Market & Enterprise Value
Market Cap
4.85B EUR
5.35B EUR
2.75B EUR
3.47B EUR
Enterprise Value
5.03B EUR
5.85B EUR
2.99B EUR
3.71B EUR
Valuation Multiples
Trailing P/E
--
--
--
221.57x
Forward P/E
9.24x
--
--
--
Price to Sales
8.2x
9.05x
5.12x
8.49x
Price to Book
200.48x
218.17x
27.81x
30.26x
EV/Revenue
8.51x
9.89x
5.58x
9.07x
EV/EBITDA
219.66x
1,012.33x
77.71x
77.7x
Price to FCF (P/FCF)
--
352.81x
--
103.38x
EV/FCF
--
385.73x
--
110.4x
FCF Yield
-0.38%
0.28%
-1.05%
0.97%
ende